GlassScriptPhysician profile
Naveed Iqbal
NPI 1609075928
$970.73
in general payments reported to CMS, 2019-2025
20 companies · $37.44 in 2025
The $37.44 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $933 · 2025: $37.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $37.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $37.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $143.94 | 2019 | |
| Merck Sharp & Dohme LLC | $131.44 | 2019 | |
| Medtronic Minimed, INC. | $87.88 | 2019 | |
| Novo Nordisk INC | $85.82 | 2019 | |
| Amgen INC. | $68.64 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $59.52 | 2019 | |
| Dexcom, INC. | $52.89 | 2019 | |
| Insulet Corporation | $52.51 | 2019 | |
| Sanofi-Aventis U.S. LLC | $51.83 | 2019 | |
| Lilly USA, LLC | $39.78 | 2019 | |
| Teleflex LLC | $37.44 | 2025 | Barrigel |
| Valeritas, INC. | $27.29 | 2019 | |
| Becton, Dickinson and Company | $20.75 | 2019 | |
| Shire North American Group INC | $20.60 | 2019 | |
| Companion Medical, INC. | $19.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $16.56 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.05 | 2019 | |
| Lifescan, INC. | $14.99 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.02 | 2019 | |
| Ibsa Pharma INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naveed Iqbal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.